Cargando…

New Oral Anticoagulants for Thromboprophylaxis after Elective Total Hip and Knee Arthroplasty

Anticoagulant drugs reduce the risk of venous thromboembolic events after total hip and knee arthroplasty. However, the use of current drugs, such as low molecular weight heparins, is hampered by their subcutaneous route of administration. The use of vitamin K antagonists is hampered by the requirem...

Descripción completa

Detalles Bibliográficos
Autor principal:	Friedman, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211075/ https://www.ncbi.nlm.nih.gov/pubmed/22084658 http://dx.doi.org/10.1155/2010/280731

Ejemplares similares

Practical management of new oral anticoagulants after total hip or total knee arthroplasty
por: Klauser, W., et al.
Publicado: (2013)

The effect of new oral anticoagulants and extended thromboprophylaxis policy on hip and knee arthroplasty outcomes: observational study
por: Bottle, Alex, et al.
Publicado: (2015)

Thromboprophylaxis for Total Knee Arthroplasty
por: Gali, Julio Cesar, et al.
Publicado: (2019)

Comparative study of extended versus short term thromboprophylaxis in patients undergoing elective total hip and knee arthroplasty in Indian population
por: Nair, Velu, et al.
Publicado: (2013)

Lupus and Perioperative Complications in Elective Primary Total Hip or Knee Arthroplasty
por: Aziz, Keith T., et al.
Publicado: (2020)

Venous thromboembolism is rare after total hip and knee joint arthroplasty with long thromboprophylaxis in Finnish fast-track hospitals
por: Moisander, Annette M., et al.
Publicado: (2023)

Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis
por: Lindquist, Desirae E., et al.
Publicado: (2018)

Optimal duration of anticoagulant thromboprophylaxis in total hip arthroplasty: new evidence in 55,540 patients with osteoarthritis from the Nordic Arthroplasty Register Association (NARA) group
por: Pedersen, Alma B, et al.
Publicado: (2019)

Oral Thromboprophylaxis Following Total Hip or Knee Replacement: Review and Multicentre Experience with Dabigatran Etexilate
por: Kendoff, D, et al.
Publicado: (2011)

Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials
por: Ning, Guang-Zhi, et al.
Publicado: (2016)

Thromboelastography in elective total hip arthroplasty
por: Lloyd-Donald, Patryck, et al.
Publicado: (2021)

The feasibility of achieving Elective Care Framework targets for total hip arthroplasty and total knee arthroplasty in Northern Ireland
por: Mayne, Alistair I. W., et al.
Publicado: (2022)

Early rehabilitation after elective total knee arthroplasty
por: Lisi, Claudio, et al.
Publicado: (2017)

Incidence, predictors, and timing of post-operative stroke following elective total hip arthroplasty and total knee arthroplasty
por: Haynes, Monique S., et al.
Publicado: (2020)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)

Association between duration of anticoagulant thromboprophylaxis and revision rate in primary total hip arthroplasty: a Danish and Norwegian nationwide cohort study
por: VINTHER, Dennis, et al.
Publicado: (2022)

New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis
por: Yi, Yi-hu, et al.
Publicado: (2022)

Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty
por: Santana, Daniel C., et al.
Publicado: (2021)

Skin Necrosis Associated with Thromboprophylaxis after Total Knee Replacement
por: Karuppiah, S. V., et al.
Publicado: (2014)

Is Routine Hemoglobin Monitoring Necessary after Elective Hip and Knee Arthroplasty?
por: Hennessy, Orla, et al.
Publicado: (2020)

Lessons Learned: Using the Caprini Risk Assessment Model to Provide Safe and Efficacious Thromboprophylaxis Following Hip and Knee Arthroplasty
por: Krauss, Eugene S., et al.
Publicado: (2020)

Letter to the Editor: Potent Anticoagulants Are Associated with a Higher All-cause Mortality Rate After Hip and Knee Arthroplasty
por: Eriksson, Bengt I., et al.
Publicado: (2008)

Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study
por: Yhim, Ho-Young, et al.
Publicado: (2017)

Thromboprophylaxis only during hospitalisation in fast-track hip and knee arthroplasty, a prospective cohort study
por: Jørgensen, Christoffer C, et al.
Publicado: (2013)

Jump in Elective Total Hip and Knee Arthroplasty Numbers at Age 65 Years: Evidence for Moral Hazard?
por: Rankin, Kelsey A., et al.
Publicado: (2022)

The Association of Delirium with Perioperative Complications in Primary Elective Total Hip Arthroplasty
por: Aziz, Keith T, et al.
Publicado: (2018)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

CLINICAL OUTCOME AFTER INFECTED TOTAL KNEE AND TOTAL HIP ARTHROPLASTY
por: Mittag, Falk, et al.
Publicado: (2016)

Postdischarge Opioid Use after Total Hip and Total Knee Arthroplasty
por: Atwood, Keenan, et al.
Publicado: (2021)

Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis
por: Borgen, Pål O., et al.
Publicado: (2013)

Safety and efficacy of a new thromboprophylaxis regiment for total knee and total hip replacement: a retrospective cohort study in 265 patients
por: Fallaha, Mohammad Amre, et al.
Publicado: (2018)

Computer assisted navigation in total knee and hip arthroplasty
por: Deep, Kamal, et al.
Publicado: (2017)

Venous Thromboembolism in Total Hip and Total Knee Arthroplasty
por: Simon, Samantha J., et al.
Publicado: (2023)

Race, Rehabilitation, and 30-Day Readmission After Elective Total Knee Arthroplasty
por: Jorgenson, Erik S., et al.
Publicado: (2015)

Fondaparınux Versus Nadroparın for Preventıon of Venous Thromboembolısm After Electıve Hıp and Knee Arthroplasty()
por: Argun, Mahmut, et al.
Publicado: (2013)

The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty
por: Russell, Robert D., et al.
Publicado: (2013)

The use of pre-operative Inferior Vena Cava filters for thromboprophylaxis in ultra-high-risk patients undergoing total hip and knee arthroplasty: a systematic review and narrative analysis
por: Sochart, Sarita, et al.
Publicado: (2023)

Evaluating comorbidities in total hip and knee arthroplasty: available instruments
por: Bjorgul, Kristian, et al.
Publicado: (2010)

Association of Race/Ethnicity With Hospital Discharge Disposition After Elective Total Knee Arthroplasty
por: Singh, Jasvinder A., et al.
Publicado: (2019)

Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis
por: Wu, Cheng-Ta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jg595cqpcidac54rjc5fnr5h6e